“Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients”., Precis. Med. Com., vol. 2, no. 2, pp. 91–108, Dec. 2022, doi: 10.55627/pmc.002.02.0188.